DK1856125T3 - Syntese af proteasehæmmerforstadie - Google Patents

Syntese af proteasehæmmerforstadie

Info

Publication number
DK1856125T3
DK1856125T3 DK06724879T DK06724879T DK1856125T3 DK 1856125 T3 DK1856125 T3 DK 1856125T3 DK 06724879 T DK06724879 T DK 06724879T DK 06724879 T DK06724879 T DK 06724879T DK 1856125 T3 DK1856125 T3 DK 1856125T3
Authority
DK
Denmark
Prior art keywords
synthesis
protease inhibitor
inhibitor precursor
precursor
processes
Prior art date
Application number
DK06724879T
Other languages
Danish (da)
English (en)
Inventor
Bruno Linclau
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Application granted granted Critical
Publication of DK1856125T3 publication Critical patent/DK1856125T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
DK06724879T 2005-02-25 2006-02-24 Syntese af proteasehæmmerforstadie DK1856125T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05101462 2005-02-25
US68369905P 2005-05-23 2005-05-23
PCT/EP2006/060246 WO2006089942A1 (fr) 2005-02-25 2006-02-24 Synthese de precurseur d'inhibiteur de la protease

Publications (1)

Publication Number Publication Date
DK1856125T3 true DK1856125T3 (da) 2009-12-07

Family

ID=36646227

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06724879T DK1856125T3 (da) 2005-02-25 2006-02-24 Syntese af proteasehæmmerforstadie

Country Status (19)

Country Link
US (2) US8067463B2 (fr)
EP (1) EP1856125B1 (fr)
JP (1) JP5260965B2 (fr)
KR (1) KR101333627B1 (fr)
CN (1) CN101128469B (fr)
AT (1) ATE440848T1 (fr)
AU (1) AU2006217922B2 (fr)
BR (1) BRPI0607827B8 (fr)
CA (1) CA2595295C (fr)
DE (1) DE602006008751D1 (fr)
DK (1) DK1856125T3 (fr)
ES (1) ES2331257T3 (fr)
IL (1) IL184519A (fr)
MX (1) MX2007010378A (fr)
NO (1) NO20074880L (fr)
PL (1) PL1856125T3 (fr)
PT (1) PT1856125E (fr)
RU (1) RU2421459C2 (fr)
WO (1) WO2006089942A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5288153B2 (ja) * 2007-03-30 2013-09-11 日油株式会社 糖アルコール誘導体およびアルケニル基含有糖アルコール誘導体の製造方法
US8802724B2 (en) * 2010-11-30 2014-08-12 Purdue Research Foundation Processes and intermediates for preparing substituted hexahydrofuro [2,3-b] furans

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE500823T1 (de) 1998-06-23 2011-03-15 Us Of America Represented By The Secretary Dept Of Health And Human Services Arzneimittel zur behandlung von hiv-infizierten säugetieren
WO1999067254A2 (fr) 1998-06-23 1999-12-29 The United States Of America Represented By The Secretary, Department Of Health And Human Services Inhibiteurs de protease retrovirale resistant a l'action de plusieurs medicaments et procedes associes
EP1089328A1 (fr) 1999-09-29 2001-04-04 Infineon Technologies AG Méthode de formation d'un dispositif semiconducteur
AP1459A (en) 1999-10-06 2005-08-22 Tibotec Pharm Ltd Hexahydrofuro [2,3-b] furan-3- YL-N-{3-[(1,3- benzodioxol-5- ylsufonyl) (isobutyl) amino]-1-benzyl-2-hydroxypropyl} carbamate as retroviral protease inhibitor.
CA2438304C (fr) 2001-02-14 2011-04-12 Dominique Louis Nestor Ghislain Surleraux Sulfamides de 2-amino-benzothiazole substitue en tant qu'inhibiteurs de la protease du vih a large spectre
HUP0303744A3 (en) 2001-04-09 2008-03-28 Tibotec Pharm Ltd Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide hiv protease inhibitors and pharmaceutical compositions containing them
PL209029B1 (pl) 2001-05-11 2011-07-29 Tibotec Pharm Ltd Pochodne 2-aminobenzoksazolo-sulfonamidów jako inhibitory proteazy HIV, oraz kompozycje zawierające te związki
US7087373B2 (en) 2001-06-05 2006-08-08 Tibotec Pharmaceuticals Ltd. Methods for determining plasma free drug concentration by direct measurement of binding affinity of protease inhibitors to plasma proteins
TWI286476B (en) 2001-12-12 2007-09-11 Tibotec Pharm Ltd Combination of cytochrome P450 dependent protease inhibitors
PL216539B1 (pl) 2001-12-21 2014-04-30 Tibotec Pharm Ltd Związki fenylosulfonylowe i zastosowanie związków fenylosulfonylowych
EP1483254A4 (fr) 2002-01-07 2005-06-08 Sequoia Pharmaceuticals Inhibiteurs de protease retrovirale anti-resistance
CA2474671A1 (fr) 2002-02-22 2003-08-28 Tibotec Bvba Procedes de determination de l'influence du plasma ou la liaison de proteines seriques humains sur l'activite antiretrovirale
US7157489B2 (en) 2002-03-12 2007-01-02 The Board Of Trustees Of The University Of Illinois HIV protease inhibitors
MY142238A (en) 2002-03-12 2010-11-15 Tibotec Pharm Ltd Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
TWI332956B (en) 2002-04-26 2010-11-11 Gilead Sciences Inc Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds
SI1567529T2 (sl) 2002-05-16 2021-08-31 Janssen Sciences Ireland Unlimited Company Psevdopolimorfne oblike zaviralca HIV proteaze
DK1517899T3 (da) 2002-05-17 2007-12-03 Tibotec Pharm Ltd Bredspektret substitueret benzisoxazolsulfonamid HIV-proteaseinhibitor
US7217506B2 (en) 2002-07-01 2007-05-15 Tibotec Pharmaceuticals, Ltd. Mutational profiles in HIV-1 protease correlated with phenotypic protease inhibitor resistance

Also Published As

Publication number Publication date
BRPI0607827A2 (pt) 2009-10-06
EP1856125A1 (fr) 2007-11-21
ES2331257T3 (es) 2009-12-28
PL1856125T3 (pl) 2010-01-29
JP5260965B2 (ja) 2013-08-14
CN101128469B (zh) 2012-11-14
IL184519A (en) 2012-01-31
US8183394B2 (en) 2012-05-22
AU2006217922A1 (en) 2006-08-31
KR101333627B1 (ko) 2013-11-27
PT1856125E (pt) 2009-11-06
MX2007010378A (es) 2007-09-25
EP1856125B1 (fr) 2009-08-26
IL184519A0 (en) 2007-10-31
US20120041215A1 (en) 2012-02-16
NO20074880L (no) 2007-09-25
CA2595295C (fr) 2014-07-08
BRPI0607827B8 (pt) 2021-05-25
WO2006089942A8 (fr) 2007-12-13
KR20080005183A (ko) 2008-01-10
US20090054668A1 (en) 2009-02-26
BRPI0607827B1 (pt) 2019-11-05
RU2007135345A (ru) 2009-03-27
ATE440848T1 (de) 2009-09-15
DE602006008751D1 (de) 2009-10-08
US8067463B2 (en) 2011-11-29
JP2008531522A (ja) 2008-08-14
WO2006089942A1 (fr) 2006-08-31
RU2421459C2 (ru) 2011-06-20
AU2006217922B2 (en) 2012-04-05
CA2595295A1 (fr) 2006-08-31
CN101128469A (zh) 2008-02-20

Similar Documents

Publication Publication Date Title
CR7680A (es) Un nuevo proceso para la sintesis de agomelatina
CY1112467T1 (el) Παραγωγα 1-θειο-d-γλυκιτολης
BRPI0615029A2 (pt) processos e intermediários
EA200500201A1 (ru) Новый способ синтеза (7-метокси-1-нафтил)ацетонитрила и его применение при синтезе агомелатина
BRPI0615705A2 (pt) processo para preparar um composto, e, composto
MX2007003118A (es) Procedimiento de intermediarios para preparar inhibidores de cisteina proteasa.
BRPI0710199A2 (pt) Processo para preparação de inibidores de hiv protease
EA200500202A1 (ru) Новый способ синтеза (7-метокси-3,4-дигидро-1-нафталинил)ацетонитрила и его применение при синтезе агомелатина
MX2007014172A (es) Procedimiento para la produccion de 4-bifenililacetidina-2-onas fenolicos.
CY1110010T1 (el) Πυριδιναμινοσουλφονυλ υποκατεστημενα βενζαμιδια ως αναστολεις κυτοχρωματος ρ450 3α4 (cyp3a4)
TW200640914A (en) Novel processes for the preparation of a benzofuran
ITMI20050801A1 (it) Procedimento per la preparazione di telmisartan
AR054533A1 (es) Proceso y reactivo magnetico para la separacion de impurezas de los minerales
MX2009000480A (es) Bencilaminas, un proceso para su produccion y su uso como agentes antiinflamatorios.
EA201000257A1 (ru) Новый способ синтеза (7-метокси-l-нафтил) ацетонитрила и применение в синтезе агомелатина
TW200728310A (en) Process for the preparation of ferri-succinylcasein
EA200500204A1 (ru) Новый способ синтеза (7-метокси-1-нафтил)ацетонитрила и его применение при синтезе агомелатина
IL189286A0 (en) Novel cysteine protease inhibitors and their therapeutic applications
NI200700175A (es) Procesos para la preparación de alcoholes de aminoetoxibencilo
DK1856125T3 (da) Syntese af proteasehæmmerforstadie
NO20083730L (no) Fremgangsmate for fremstilling av entakapon
TW200728267A (en) Processes and intermediates for the preparation of prostaglandins
UA94391C2 (ru) Синтез предшественника ингибитора протеазы
EA200802065A1 (ru) Синтез замещённых флуоренов
CY1115133T1 (el) Μεθοδος παρασκευης αναστολεων hiv πρωτεασης